Home

Surichinmoi tsunami quil sagisse achim aigner leipzig university germany froissé voleur Pour donner la permission

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

Rudolf-Boehm-Institut für Pharmakologie und Toxikologie
Rudolf-Boehm-Institut für Pharmakologie und Toxikologie

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

Tyrosine-Modification of Polypropylenimine (PPI) and Polyethylenimine (PEI)  Strongly Improves Efficacy of siRNA-Mediated Gene Kn
Tyrosine-Modification of Polypropylenimine (PPI) and Polyethylenimine (PEI) Strongly Improves Efficacy of siRNA-Mediated Gene Kn

Module III – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich
Module III – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich

Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma
Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

Leipziger Pharmakologen forschen an Molekülen gegen Prostatakrebs
Leipziger Pharmakologen forschen an Molekülen gegen Prostatakrebs

Functional Role and Therapeutic Potential of the Pim-1 Kinase in Colon  Carcinoma
Functional Role and Therapeutic Potential of the Pim-1 Kinase in Colon Carcinoma

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

MicroRNAs (miRNAs) in Colorectal Cancer: From Aberrant Expression Towards  Therapy
MicroRNAs (miRNAs) in Colorectal Cancer: From Aberrant Expression Towards Therapy

Perspectives, issues and solutions in RNAi therapy: the expected and the  less expected
Perspectives, issues and solutions in RNAi therapy: the expected and the less expected

Therapeutic Targeting of Stat3 Using Lipopolyplex Nanoparticle-Formulated  siRNA in a Syngeneic Orthotopic Mouse Glioma Model
Therapeutic Targeting of Stat3 Using Lipopolyplex Nanoparticle-Formulated siRNA in a Syngeneic Orthotopic Mouse Glioma Model

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

SiRNA-transfection of SKOV-3-Luc cells with the Biontex K2® Transfection  System Dipl.-Chem. Alexander Ewe, Prof. Achim Aigner U
SiRNA-transfection of SKOV-3-Luc cells with the Biontex K2® Transfection System Dipl.-Chem. Alexander Ewe, Prof. Achim Aigner U

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

Loop | Achim Aigner
Loop | Achim Aigner

application note Metafectene K2 Adipocyten-pDNA - final
application note Metafectene K2 Adipocyten-pDNA - final

SiSaf and the University of Leipzig Partner to Develop Bio-Courier Targeted  miRNA for the Treatment of Pancreatic Cancer
SiSaf and the University of Leipzig Partner to Develop Bio-Courier Targeted miRNA for the Treatment of Pancreatic Cancer

Achim Aigner | Leipzig University, Germany | Pharmaceutica 2017 |  Conferenceseries
Achim Aigner | Leipzig University, Germany | Pharmaceutica 2017 | Conferenceseries

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

MedChemComm
MedChemComm

Universität Leipzig: Beschäftigte, Standort, Ehemalige | LinkedIn
Universität Leipzig: Beschäftigte, Standort, Ehemalige | LinkedIn